Enrolling: NIH Intramural Study

Overview

The objective of this research study is to look in-depth at the clinical and biological characteristics of ME/CFS. Participants with ME/CFS are inpatients at the clinical center at NIH for approximately two weeks on their first visit and another two weeks if they return for the second round of the study.

There will be a total of 40 people with ME/CFS, 40 healthy controls, and 20 people with successfully treated Lyme disease in the study. The study is open to international participants.


Participants must meet the following qualifications:
– Sudden onset after an infection
– Meet the Canadian Consensus Criteria and Fukuda Criteria
– Be between the ages of 18 and 60
– Severe symptoms that started between six months and five years ago
– Be able to participate in all of the tests listed at https://mecfs.ctss.nih.gov/, including a one-day exercise test


Who:

The study is run out of the Clinical Center at NIH by Dr Nath, intramural clinical director of the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health. Scientists at NIH from ten institutes are working on different aspects of the protocol.


When:

Ongoing


How to Participate:

Email: [email protected] or [email protected]
Call: 301-496-1788


What:

The study looks at a wide range of symptoms and potential co-existing disorders including POTS, PEM, cognitive problems, potential mitochondrial issues, and muscle disorders. There are also studies into genetics and gene expression. The study website at https://mecfs.ctss.nih.gov/ includes details on tests that will be done throughout the study.

After your first visit, an adjudication panel of expert clinicians will review your case, including written notes and test results, and confirm that you meet the Canadian Consensus Criteria and Fukuda Criteria and don’t have any disqualifying co-existing conditions. If all of the clinicians believe that you meet the relevant criteria, then you will be invited back for a second visit that will include more tests.
The expert clinicians are:

  • Anthony Komaroff
  • Daniel Peterson
  • Lucinda Bateman
  • Andreas Kogelnik
  • Benjamin Natelson

Dr Nath is also on the review panel.

NBC News did an article on the study at https://www.nbcnews.com/health/health-news/nih-study-takes-deepest-dive-yet-baffling-condition-n754271


Where:

NIH Clinical Center, Bethesda, MD, USA


Compensation:

NIH will cover the cost of a flight from anywhere in the US for US participants and a caretaker, along with providing a hotel room for the caretaker. International participants are welcome but will have to arrange their own travel to NIH in Bethesda, MD.

You will receive $560 for completing the first visit and an additional $50 for completing cytapheresis. You will receive $1015 for completing the second visit, including the exercise test. You will receive an additional $100 for getting an optional skin biopsy done and $250 for getting an optional muscle biopsy done.

Facebook
Twitter
WhatsApp
Email

Latest News

a dark plum square image with a brownish/purple square in the middle. The #MEAction logo is at the top center. the words: black ME voices: q&a with Teona Studemire are in a fancy white font. Black history month is at the bottom of the square surrounded by two black stars.

 Black ME Voices: Q&A with Teona Studemire

With it being Black History Month, it was crucial to me to make sure we spotlighted someone from the ME/CFS and Long COVID community who is Black. Being Black and disabled is an entirely different experience. Not only do we deal with ableism, but we also deal with racism, especially medical racism. According to the

Read More »
blue rectangle image with the NIH logo in the top left hand corner. the words: NIH MECFS Research Roadmap Update Public comments open until March 8th appear in the middle of the image. the meaction logo is in the bottom right hand corner.

NIH ME/CFS Research Roadmap Update–Public Comment Period Now Open

The NIH ME/CFS Research Roadmap public comment period is open now with a deadline of March 8th.  #MEAction is a member of the ME/CFS Research Roadmap Working Group and for the past several months we have been advocating on behalf of this community within this group. Our Executive Director, Laurie Jones, served on the nervous

Read More »
Scroll to Top